Development of a nurse-led service for patients receiving oral capecitabine
Intended for healthcare professionals
Clinical Previous     Next

Development of a nurse-led service for patients receiving oral capecitabine

Karen Harrold Chemotherapy Nurse Specialist, Chemotherapy Day Unit, Mount Vernon Centre for Cancer Treatment, Northwood, Middlesex

This article discusses the introduction by one cancer centre of oral chemotherapy agent capecitabine (or Xeloda*). Patients are able to administer this preparation to themselves at home. The author provides a largely descriptive account of the centre’s role in ensuring patients receiving oral chemotherapy are provided with the same high level of quality care, information and support from the specialist chemotherapy nursing team as those receiving conventional intravenous chemotherapy.

Cancer Nursing Practice. 1, 8, 19-24. doi: 10.7748/cnp2002.10.1.8.19.c8102

Want to read more?

Already subscribed? Log in

OR

Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
Subscribe
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or